• Pediatric Conjunctivitis: Clinical Decision-making for Optimal Treatment
  • CME

  • Pediatric Conjunctivitis: Clinical Decision-making for Optimal Treatment

  • Author(s)/Faculty: Michael E Pichichero, MD; David B Granet, MD; Rudolph S Wagner, MD
    Source: Pediatric SuperSite
    Type: Monograph Articles/Items: 0
    Release Date: 5/1/2011 Expiration Date: 5/31/2012
    Credit Type: CME Number of Credit(s): 1.25
    Cost: Free Provider: Vindico Medical Education
  • Conjunctivitis is a common condition in pediatric patients. In this monograph, experts will explain how to differentiate among bacterial, viral, and allergic conjunctivitis. The benefit of treating bacterial conjunctivitis even though it is a self-limiting disease will be explained. Available treatments for bacterial conjunctivitis will be reviewed, along with their resistance patterns. Case studies will exemplify the implementation of theory into practice.

Sponsorship Statement: This continuing education activity is jointly-sponsored by Infectious Diseases in Children and Vindico Medical Education

Support Statement: This activity is supported by an educational grant from Bausch & Lomb

Target Audience: The intended audience for this activity is pediatricians, pediatric nurse practitioners, and other health care professionals involved in the treatment of pediatric patients.

Learning Objectives:

After completing this activity, participants should be able to:

  • Differentiate between bacterial and viral conjunctivitis.
  • Debate the use of antimicrobial therapy for the treatment of bacterial conjunctivitis and discuss the safety and efficacy of current antimicrobials.
  • Evaluate current and emerging therapeutics for the treatment of bacterial conjunctivitis.
Course Chair:
Michael E. Pichichero, MD
Director, Research Institute
Rochester General Hospital
Director, Center for Infectious Diseases and Immunology
Research Institute at Rochester General Hospital
Rochester, NY

Faculty:
David B. Granet, MD
Anne F. Ratner Professor of
Ophthalmology and Pediatrics
University of California, San Diego
Director, Pediatric Ophthalmology and Adult Re-Alignment Services
Anne F. and Abraham Ratner Children’s Eye Center
Shiley Eye Center
University of California, San Diego
La Jolla, CA
Title: Treating Bacterial Conjunctivitis

Rudolph S. Wagner, MD
Editorial Board Member
Ocular Surgery News®
Editor
Journal of Pediatric Ophthalmology and Strabismus
Clinical Associate Professor of Ophthalmology & Pediatrics
Director, Pediatric Ophthalmology & Strabismus
UMDNJ - New Jersey Medical School
Newark, NJ
Title: Differentiating Bacterial Conjunctivitis from Allergic and Viral Conjunctivitis

Peer Reviewer:
Thomas J. Selva, MD

Medical Writer:
Cara Powers, MD

Accreditation:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Infectious Diseases in Children® and Vindico Medical Education. Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:
Vindico Medical Education designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

This enduring material is approved for 1 year from the date of original release, May 1, 2011 to May 31, 2012.

How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, read the articles, complete the CME posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate within 4 to 6 weeks.

Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.

Planning Committee and Faculty members report the following relationship(s):
Michael E. Pichichero, MD
No relevant financial relationships to disclose

David B. Granet, MD
Consulting Fees: Alcon Laboratories, Inc

Rudolph S. Wagner, MD
Consulting Fees: Alcon Laboratories, Inc
 
Peer Reviewer reports the following relationship(s):
Thomas J. Selva, MD
No relevant financial relationships to disclose

Medical Writer reports the following relationship(s):
Cara Powers, MD
No relevant financial relationships to disclose

Infectious Diseases in Children® and Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Copyright © 2011 SLACK Incorporated®. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Infectious Diseases in Children® and Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Infectious Diseases in Children® and Vindico Medical Education. Neither Infectious Diseases in Children®, Vindico Medical Education, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.